chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme joint pain for approx. 24 hrs post-vaccination. Moderate to severe lower back pain beginning approx. 10 a.m. 4/13/21, resolving approx. 4/14/21 8 a.m., and returning at moderate-severe level approx. 7 a.m. 4/17/21. Pain is worse when sitting or laying down and aggravated when rising from seated position. Soreness and sharp pain is mostly bilateral with some possibly more tenderness to the left side pelvic area. OTC pain-relievers (ibuprofen 200mg) are being used to relieve pain with limited success. Pain has been consistent since 4/17/21. No accompany nausea, no headache, slight chills that subsided; joint pain is the primary concern.
I felt tired the day of the shot and slept for about 16 hours. I had no apatite and couldn't get up off the couch because my body felt so bad. The next day and several days later I felt like I couldn't eat, drink, and my stomach hurt really bad. I still continued to feel tired and didn't have the energy to do much. It felt like a Crohn's flareup. I called my gastrointestinal specialist and she gave me some medicine to help. I started to get my energy back and felt like eating and drinking again. A week goes by and I started getting a sore throat and the tired feeling again, and started having some vaginal issues. I ended up getting thrush and a yeast infection. I haven't had a flareup in 5 or 6 years and as soon as I took the covid-19 vaccine I got really sick. I thought I should report this just in case anyone else with auto immune disease would have the same issues. I am better and no harm was done other than several medications and a couple of weeks of not feeling well.
stings; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of stinging in an unspecified number of patient's who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced stinging (Verbatim: stings). The outcome of the stinging was unknown.   It was unknown if the reporter considered the stinging to be related to Arexvy.   It was unknown if the company considered the stinging to be related to Arexvy.   Additional Information: GSK Receipt Date: 31-OCT-2023 A GSK Field Representative reported that a pharmacist stated that of 169 patients that received the vaccine Arexvy at a local pharmacy, the most common comment from the patients was that the vaccine stings. The pharmacist stated that the ratio was 50/50 for male and female patients. No additional information was provided. The reporter consented to follow up. This case is for female patient's and is linked to US2023151159 for male patient's reported by same reporter.; Sender's Comments:  US-GSK-US2023151159:Male Patients case
I noticed that I had hives on my right forearm. I took 25 mg of benadryl, and the hives went away. This occured at 10:00 PM, approximately 12 hours after the vaccination.
High pitched noise in the ears; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 18:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included overweight. The patient was allergic to penicillin. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 20:45, two hours after the vaccine, the patient experienced high pitched noise in the ears, which lasted 40 minutes and it had come back, lasting about seven hours and counting. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event high pitched noise in the ears was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt had to go to ER, had severe pain, big knot, blood clot and scar at injection site. After 2 months still got black spot at injection site.
On 09/23/2020 patient came in to receive a flu shot. FluBlok was administered to left deltoid of patient. Rx# 6706598. Approximately 10 minutes after receiving the flu shot, patient came to pharmacy window complaining of tingling sensation in her left arm and thumb. I then advised her to come into the immunization room for further screening and questions. Patient has received flu shot in the past and denied any prior reactions to flu shots or vaccines in the past, and denied having any underlying health conditions or taking any medications. As patient was sitting in the vaccination room, she complained of the numbing sensation now going up her entire left arm and losing feeling in all 5 left fingers, blurry vision, inability to feel her face, and could no longer speak in full sentences due to shortness of breath. This is when I called 911. The paramedics arrived within minutes and immediately checked patient?s vitals and began questioning. Her blood pressure and heart rate were significantly elevated and paramedics performed breathing exercises with patient as she continued to hyperventilate. After 15 minutes, patient?s hyperventilation and vitals did not subside, and the paramedics decided it was best to take the patient to the hospital as they could not diagnose her at the scene. We later confirmed with the paramedics and they were concluding that it might have been a panic attack.
The patient got the second shot and developed severe arm/shoulder pain that night. NSAIDS were taken and a steroid dospak was given. Symptoms remained and referral was made to orthopedic for shoulder. As per patient, he diagnosed her with bursitis as put her on anti-inflammatory medication. The reason for the report is that the patient stated the vaccine was given high up in her arm and believes it was possibly caused by that. The pain has lasted weeks and is now just improving she states on anti inflammatory medicine.
THIS WAS REPORTED TO ME SECOND HAND ON 9/21/15- PATIENT REPORTED TO PHARMACY WHEN I WAS OFF WITH EXTENSIVE BRUISE AT INJECTION SITE.
She presents complaining of tenderness over the left breast. Pain began this morning and worsened after a friend socked her in the left arm. Pain is rated 7 out of 10.  Approximately,  15 minutes after sucking a 325 mg ASA in the Office pain is down to a "2."
Initial unsolicited report received from a physician on 23 September 2015. This case involves a 48 years old male patient who was vaccinated with a dose of ADACEL (batch number:U5209AA), (dose, dose number were unknown) via intramuscular route in the left deltoid on 21 September 2015. The patient's medical history and concomitant medications were unknown. It was reported that, on 23 September 2015 (2 days after vaccination) the patient had the following events: large, red, swollen, warm to touch, painful area of upper left arm to shoulder with a fine, macular and light red rash at same area of left arm. Lab data was unknown. It was reported that patient was treated with NSAIDS as corrective treatment. The outcome of the events fine, macular, light red rash at same area of left arm and large, red, swollen, warm to touch, painful area of upper left arm to shoulder were not recovered. The patient was advised for ER/doctor visit and the physician had ruled out cellulitis. List of documents held by sender: none.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 26-SEP-2013 the patient was vaccinated with M-M-R II (reported lot # H018950 corresponding with lot # 1483AA; expiration date 18-OCT-2014). The vaccine was exposed to temperature exposures of 50F for 85 minutes, 47F for 15 minutes, 48F for 35 minutes, 52 F for 95 minutes, 48F for 30 minutes on 20-SEP-2013 and 48F for 45 minutes on 25-SEP-2013. No known adverse effects. This case is linked to case 1310USA001610, 1310USA008360, 1310USA008361, 1310USA008362, 1310USA008363, 1310USA008364, 1310USA008365, 1310USA008366, 1310USA008367,  1310USA008368, 1310USA008369, 1310USA008370, 1310USA008371, 1310USA008372, 1310USA008373, 1310USA008374, 1310USA008375, 1310USA008376, 1310USA008377, 1310USA008378, 1310USA008379, 1310USA008380, 1310USA008381, 1310USA008382, 1310USA008383, 1310USA008384, 1310USA008385, 1310USA008386, 1310USA008387, 1310USA008388, 1310USA008389, 1310USA008390, 1310USA008391, 1310USA008392, 1310USA008393, 1310USA008394, 1310USA008395, 1310USA008396, 1310USA008397, 1310USA008398, 1310USA008399,1310USA008400,  1310USA008401, 1310USA008402, 1310USA008403,1310USA008404,  1310USA008405, 1310USA008406 and 1310USA008407 (same reporter linked). Additional information has been requested.
received the pediatric dose as dose 1 even though was 12 years old at the time
Information has been received from a 24 year old female pt, who is a RN, who on an unk date was vaccinated with a first dose of varicella virus vaccine live. After that initial information with varicella virus vaccine live, she was found to have a negative titer. On an unspecified date in approx Apr 2005, the pt was vaccinated with a second dose of varicella virus vaccine live. After receipt of the second dose, the injection site became swollen, hard and hot to touch. Medical attention was sought and she was treated with an antibiotic. It was reported that the pt recovered on an unk date. There was no product quality complaint reported. Swollen, hard and a hot to touch injection site were considered to other important medical events by the reporter (OMIC). Additional information has been requested.
We had been traveling out of state. We picked up our grandkids to take them to a museum and then travelled home on 07/07/2022. While vacationing, I noticed some back pain and went to a doctor when I returned home due to a rash. He prescribed prednisone for the rash at that time. That weekend, my husband came down with COVID-19 and I tested positive shortly after him. On 07/11/2022 I had a runny/stuffy nose and a dry cough. I took an at home COVID-19 test and it was positive. I called my doctor for myself and my husband who prescribed PAXLOVID for both of us. He also looked at my rash again and decided that it was shingles. I didn't feel like the PAXLOVID effected my symptoms much but a few days later, my cough became more productive and that lasted for 3 or 4 days. I never ran a fever and my COVID-19 symptoms improved from there. After my symptoms improved, my doctor prescribed LYRICA for the shingles. I'm still experiencing pain from the shingles, more so at night but he also prescribed trazadone for the pain to help me sleep at night.
Vaccine injection site Cellulitis, treated with course of oral antibiotics. Site red/warm/swollen and tender to touch.
The needle bent when I recieved my vaccine. I experienced pain at the time. The vaccinators was aware the needle bent. By 12am on 4/2 I was experiencing pain in my left arm and limited mobility.  The pain has not subsided and I am unable to function without sharp pain in my arm. I've experienced numbness as well. I will be seeing a physician today at urgent care.
Injection on Dec 30th, 2013. Photo Jan 11th 2014. This injection is still effecting my vitality! Today the 15th still marking and some shooting spikes like electrical shocks.
Puke; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Puke) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included BP normal (Blood pressure medium).    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VOMITING (Puke). On 18-Feb-2021, VOMITING (Puke) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Information has been received from a doctor of pharmacy concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Oka/Merck). Subsequently, "over a year ago" the patient had a hematoma from ZOSTAVAX (Oka/Merck). It was unknown if the patient sought medical attention. At the time of reporting, the patient's outcome was unknown. This is one of several cases received from the same source.  Additional information has been requested.
Case number PHHY2011US69595 is an initial spontaneous report received from a health care professional on 28 Jul 2011. This report refers to an adolescent female patient. She was given only the CYW-135 liquid component MENVEO (batch number: M10053 and expiry date: Jan 2013) intramuscularly on 28 Jul 2011. No other adverse reaction was reported.
After having Tdap administered in (L) arm, pt. started with pain and aching of the (L) upper arm, deltoid area then developed frozen shoulder.
Pharmacist received phone call from patient around noon on 2/8/22.  She reported extreme weakness in arms and legs.  Patient reports not being able to stand and having to pull self across floor, while also suffering from arm weakness.  She reports symptoms starting around 8pm on 2/7/22 and persisting until approximately 10:30am on 2/8/22.  Treatments: Patient did not report any. Outcome: Patient reports symptoms subsiding the morning of 2/8/22.
Information has been received from a physician concerning an 8 week female who on a approximately 05-JAN-2007 (two months ago) was vaccinated with the first dose of Rotateq (lot #114P, invalid). Concomitant vaccinations included "routine two and four month vaccinations. On approximately 06-JAN-2007 ( the day after first vaccination), the patient developed vomiting and had frequent foul smelling diarrhea and possible loss of weight. She was taken to the emergency room and given IV fluids. There was no evidence of intussusception. In approximately March 2007 (at four months of age). The patient was vaccinated with the second dose of Rotateq. (lot #656193/0023U). Three to four days post vaccination (on approximately March 2007), the patient was taken to the emergency room with the same experience of vomiting and diarrhea. IV Fluids were administered. There was no evidence of intussusception. There was a possible loss of weight. There was no fever with either dose. Subsequently in an unspecified date, the patient recovered from vomiting, possible weight loss, and diarrhea. The reporter felt that the vomiting, possible weight loss and diarrhea were other important medical events. Additional information has been requested.
This spontaneous report as received from a medical assistant. On an unknown date, the medical assistant reported that PROQUAD lot # M042499, expiration date: 17-APR-2018 was mistaken for M-M-R II, and it was stored improperly in the refrigerator for 14 days due to this confusion. No patients received any of the improperly stored doses of PROQUAD. No additional information was provided. A product quality complaint was not involved. Additional information has been requested.
Hives began on 9/18/22 and continue to spread across my torso and buttocks, with smaller rash on arms and legs
Pt stated on 12FEB92 lt arm was swollen & sore; pt instructed that needed to be seen immediately; states onset of sx was 4FEB92; vax given 30JAN92; pt was referred to ER on 12FEB92 afebrile but site reddened & swollen;
ALLERGIC REACTION, INIT 1/27/2022 --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Case number PHEH2014US003842 is an initial spontaneous report received from a pharmacist on 21 Feb 2014: This report refers to a 57-year-old male patient who was inadvertently vaccinated with MENVEO (batch number: M11078) intramuscularly on 29 Jan 2014. No adverse event was reported following this administration error (inappropriate age at vaccine administration).
Patient states she received flu vaccine at Employee Health on Tuesday, 12/20/16 afternoon and then about 6 hours later began to get itchy welts on her trunk and extremities and felt slight tingling on her tongue. Patient took OTC BENADRYL x 1 dose and tingling and itching of welts subsided. Left TCM 12/21/16 for Employee Health after clinic hours yesterday eve and spoke am 12/22/16 and complete form -12/22/16 asymptomatic, no welts, no SOB, no throat closing ever, tingling on tongue resolved 12/22/2016.
Patient reports fatigue, headache, faintness, tingling in tongue and extremities.  Headache, fatigue, tingling sensation started 8/27/21 and resolved Monday 8/30/21.   All have resolved except fatigue.
Narrative: Fully vaccinated, admitted for acute hypoxemic respiratory failure 2/2 COVID infection versus volume overload.
12/28/2020 Approx 10 min post vaccine pt reported feeling periorbital tingling.  She also felt an itching sensation on right arm (opposite injection site).  No rash noted.  She received 50 mg  iv Benadryl and had extended observation.  No worsening symptoms, noted at the time. She was offered ED follow-up but declined.  12/29/2020 patient noted no worsening symptoms the evening of the vaccine.  However, morning after she noted blisters in mouth.  She is following up with her primary care doctor.
R arm swollen and bruised, from shoulder to elbow on the underside. Underarm tender and swollen. Took Motrin with no relieve, as of today 4/16/21 arm is still swollen from shoulder to elbow on underside and very sore, hurts to move or bend.
third vaccine dose given overseas; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (third vaccine dose given overseas) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No specified medical history has been reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (third vaccine dose given overseas). At the time of the report, EXTRA DOSE ADMINISTERED (third vaccine dose given overseas) had resolved.            No relevant concomitant medications were reported. No treatment information was reported.
Pt diagnosed with varicella post immunization on 12/3/02. Rash onset 12/1/02. Lesions on chest and face typical of chickenpox.
blood pressure became elevated; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 56-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 20Mar2021 (at the age of 56-years-old) (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 on an unspecified date (at the age of 56-years-old) for covid-19 immunisation. The patient experienced blood pressure became elevated on 20Mar2021. The reporter stated that he have never had a high blood pressure and he did not have high blood pressure before the vaccine after he receive the vaccine he monitor him blood pressure on a regular basis and his blood pressure became elevated he went to him doctor and confirms that indeed his blood pressure was elevated and a there was nothing that had changed in his lifestyle that would have caused that other than the taking of the vaccine mmm this lasted for about a month and a half and he went back to his doctor after the vaccine the second dose of the vaccine and his blood pressure had come down to normal levels so he believe that the vaccine created some type of reaction the cause me to have high Blood pressure. perhaps information of the heart. His cardiologist who he went to him doctor believes that it is the vaccine that is the reason that his blood pressure was elevated after the backs vaccine and then about a month and a half later it was it came back down. The patient underwent lab tests and procedures which included blood pressure measurement: elevated on 20Mar2021 he receive the vaccine he monitor him blood pressure on a regular basis and his blood pressure became elevated, blood pressure measurement: came back down on 05May2021. The outcome of the event was reported as resolved on 05May2021.   Information about lot/batch number has been requested.
Pt was suspected to have developed chickenpox five years post vax.  He was seen by a physician who determined the pt did not have chickenpox but had bug bites.
There were no adverse symptoms after the first dose, other than soreness at injection site. After the second dose, there was initial arm soreness and headache with slight fatigue. Three weeks after the second injection, a noticeable increase in fatigue and muscle pain presented, which has occurred everyday for a month since that time (7 weeks after 2nd injection). Blood tests reveal no new illness, other than chronic fibromyalgia and arthritis. COVID-19 antibodies were not present in bloodwork.
tired; cold; head was in a fog; Staggering; Diarrhea; ears were ringing; arm was sore; body ache; neck was painful; back of head pain; This is a spontaneous report from a contactable consumer (Patient).  A 79-year old female consumer reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EL0140, Expiration Date Mar2021) into the left arm on 11Feb2021 at 4:00pm (at the age of 79-years-old) at single dose for COVID-19 immunization. Concomitant drugs included ciclosporin (RESTASIS) twice daily both eyes taken for dry eye; bimatoprost (LUMIGAN) one daily both eyes taken for glaucoma for 5-6 years, vitamin B complex 1 daily taken as supplement for 15-20 years; colecalciferol (D3) 2 daily during the winter and 1 daily in the summer taken as supplement for 3-4 years. She use to get a lot of sore throats. Her doctor suggested she take vitamins. Some that she took didn't help. On 11Feb2021 the patient experienced arm was sore not recovered, body ache recovered on 13Feb2021 and on 12Feb2021 she experienced tired recovered on 13Feb2021, cold recovered on 12Feb2021, head was in a fog not recovered, staggering recovered on 13Feb2021, ears were ringing recovered on 13Feb2021, Diarrhea recovered on 12Feb2021. Further reported the back of her head and neck was painful that was gone by 13Feb2021. Her arm was sore if she lays on it she can feel it. Unable to answer outcome of event for being tired,if she sits long enough she falls asleep.  Her head still feels tender. She is no longer staggering. She feels comfortable going up and down stairs. The next dose is scheduled for 04Mar2021. She is considering not taking the second dose.
Horrific headache the night she received the shot.  Headache continue to next day then eased.  Slight fever 101.  Mild body aches
Pt. received vaccine on 12-8-16. Pt. was seen in office on 12-13-16 and reported having adverse effects. Atypical chest pain - S/P immunization, arm that received injection - soreness, weakness, edema, LROM. Delayed fever, chills, eye pain, bone pain, fatigue, foot discoloration of Bilat feet. Pt. c/o slight SOA, but stated unknown if R/T injection. (Occassional SOA).